Integrative oncology research and discussions will be featured prominently during the ASCO 2011 Annual Meeting this weekend in Chicago, with several presenters among Society for Integrative Oncology leadership.
After many years advocating for integrative oncology research to be presented at the meeting, I am pleased to note that evidence-based complementary interventions are becoming part of the vanguard for oncology care, driven be consumer demand and a growing science base.
The buzz around ASCO this year is personalized oncology, an evolution of advancements in genetic and molecular diagnostics, epigenetics, proteomics, next generation of monoclonal-antibodies, other targeted therapies and more. Let there be no doubt, evidence-based integrative medicine/oncology is personalized medicine.
Sunday, June 05, 2011, 11:30AM–12:30PM
McCormick Place S100bc
Patient and Survivor Care:
Acupuncture for chemotherapy-induced fatigue: A randomized controlled trial
Gary E. Deng, MD, PhD
Memorial Sloan-Kettering Cancer Center
Saturday, June 04, 2011
McCormick Place Hall A
Antioxidant supplement use after diagnosis and breast cancer outcomes
Author(s): H. Greenlee, M. L. Kwan, L. Kushi, J. Song, A. Castillo, E. Weltzien, C. Quesenberry, B. J. Caan
Extended Education Session: Role of Nutrition, Supplements, and Integrative Medicine in Cancer Prevention, Treatment, and Survivorship
Friday, June 03, 2011
McCormick Place E353
Lifestyle Modification and Dietary Supplements in Cancer Prevention: What Is the Role?
Heather Greenlee, ND, PhD
Approaches to Nutrition Interventions During Cancer Treatment
Kimberly Robien, PhD, RD
University of Minnesota
Nutrition and Physical Activity Recommendations for Cancer Survivorship: What Do We Tell Our Patients and Their Families after Treatment?
Wendy Demark-Wahnefried, PhD, RD
University of Alabama at Birmingham
Improving Patient Outcomes: The Role of Integrative Medicine in Cancer Care
Lorenzo Cohen, PhD
University of Texas M. D. Anderson Cancer Center
Nutrition Recommendations for Patients with Far-advanced Disease
Charles L. Loprinzi, MD
Upon participation in this session, attendees will be able to:
1. Critically review dietary and micronutrient data in the oncology literature
2. Understand current data on the relationship between caloric intake, fat intake and cancer risk.
3. Understand current data on the association of supplements and cancer incidence, and their potential use as prevention agents.
4. Review the interaction between diet, micronutrients, and supplements and cancer therapies.
5. Discuss evidence-based use of other integrative therapies in the management of cancer patients.
If you plan on being at ASCO this weekend, please make sure to stop by the Society for Integrative Oncology booth (#22100, across from the Publishers Pavilion) and introduce yourself. I am a board member and will be manning the booth. We will be introducing the Eighth International SIO Conference in Cleveland this fall, which will feature a keynote from NIH Director Francis S. Collins, MD, PhD, who will speak about Body, Mind and Spirit in Oncology. Registration opened this week.
Next week FON will publish a post called Leveraging the Science, which is all about the growing science base that supports integrative medicine/oncology interventions, and how centers need to start communicating these findings internally and externally to grow clinic utilization.